SomaLogic's Protein Blood Test Shows Potential for Health Screening in Proof-of-Concept Study

NEW YORK – A team led by researchers from the University of California, San Francisco; the University of Cambridge; and Boulder, Colorado-based proteomics firm SomaLogic has demonstrated the potential of large-scale protein measurements to provide health information, including identifying patients at risk of developing certain diseases.